Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death
Journal of Medicinal Chemistry · 12.09.2024 · 67 (17) · 15098-15117
DOI: 10.1021/acs.jmedchem.4c00729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 15.08.2024. Verfasst von Meng Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jina…. Hauptthemen laut MEDLINE: Ferroptosis, Histone Deacetylase Inhibitors, Antineoplastic Agents, Benzimidazoles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Taishan Scholar Foundation of Shandong Province, National Natural Science Foundation of China, Shandong Provincial Youth Innovation Team Development Program.
Abstract (Originalsprache)
Ferroptosis is a unique type of cell death, characterized by its reliance on iron dependency and lipid peroxidation (LPO). Consequently, small-molecule ferroptosis modulators have garnered substantial interest as a promising avenue for cancer therapy. Herein, we explored the ferroptosis sensitivity of epigenetic modulators and found that the antiproliferative effects of class I histone deacetylase (HDAC) inhibitors are significantly reliant on ferroptosis. Subsequently, we developed a novel series of HDAC inhibitors, identifying HL-5s with robust inhibitory activity against class I HDACs, particularly HDAC1. Notably, HL-5s induces ferroptosis by augmenting LPO production. Mechanistically, HL-5s increased the YB-1 acetylation and inhibited the Nrf2/HO-1 signaling pathway. Furthermore, HL-5s not only significantly suppresses tumor growth in the PC-9 xenograft model but also remodels the tumor microenvironment in the LLC allograft model. Our study has unveiled that class I HDAC inhibitors can exert antitumor effects by triggering ferroptosis, and HL-5s may serve as a promising candidate for future cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, P. R. China.
- Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 26003, P. R. China.
Förderung
- Taishan Scholar Foundation of Shandong Province
- National Natural Science Foundation of China
- Shandong Provincial Youth Innovation Team Development Program
Zitieren
APA
Liu, M., Gao, S., Wang, Y., Yang, X., Fang, H., & Hou, X. (2024). Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death. Journal of Medicinal Chemistry, 67(17), 15098-15117. https://doi.org/10.1021/acs.jmedchem.4c00729
Vancouver
Liu M, Gao S, Wang Y, Yang X, Fang H, Hou X. Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death. Journal of Medicinal Chemistry. 2024;67(17):15098-15117. doi:10.1021/acs.jmedchem.4c00729
BibTeX
@article{Liu2024,
author = {Liu, Meng and Gao, Shan and Wang, Yong and Yang, Xinying and Fang, Hao and Hou, Xuben},
title = {Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {17},
pages = {15098--15117},
doi = {10.1021/acs.jmedchem.4c00729}
}
EUVIMED